PMID- 35148960 OWN - NLM STAT- MEDLINE DCOM- 20220420 LR - 20221108 IS - 2213-2945 (Print) IS - 2213-2953 (Linking) VI - 11 IP - 3 DP - 2022 May-Jun TI - Multiplex fluorescence in situ hybridization testing for anaplastic lymphoma kinase and c-ros oncogene 1 gene rearrangements on cytology smears in lung adenocarcinomas: comparative study with formalin-fixed paraffin-embedded sections. PG - 154-164 LID - S2213-2945(22)00001-1 [pii] LID - 10.1016/j.jasc.2022.01.001 [doi] AB - INTRODUCTION: Multiplex anaplastic lymphoma kinase (ALK)/c-ros oncogene 1 (ROS1) fluorescence in situ hybridization (FISH) probes conserve tissue by analyzing both ALK and ROS1 gene rearrangements (ALK-R/ROS1-R) in a single test. The positivity cutoffs have been validated on formalin-fixed, paraffin-embedded (FFPE) tissue sections and not tested on non-cell block (CB) cytology preparations. We sought to validate non-CB cytology preparations for the detection of ALK-R/ROS1-R using multiplex ALK/ROS1 FISH probes by comparing the results with matched FFPE results. MATERIALS AND METHODS: During the 3.5-year study period, FISH using the FlexISH ALK/ROS1 DistinguISH Probe (ZytoVision) was performed in non-CB cytology preparations of patients for whom FISH on FFPE sections was performed. RESULTS: A total of 20 patients had one or more non-CB cytology preparations (n = 27) suitable for FISH analysis. These comprised direct smears (n = 17), smears from centrifuged effusion pellets (n = 8), cytospin smears (n = 1), and biopsy imprint smears (n = 1). These had been fixed in 95% ethanol (n = 18) or air dried (n = 9), and stained with Papanicolaou (n = 14), May-Grunwald-Giemsa (n = 9), immunocytochemistry (n = 3), or hematoxylin and eosin (n = 1). The median archival time was 1 year. Successful FISH results were achieved in 14 samples (6 with ALK-R, 2 with ROS1-R, 6 negative) and were concordant with the FFPE FISH results for 13 of 14 cases. The single case with discordant results between cytology and FFPE FISH showed ALK-R on cytology concordant with positive ALK D5F3 companion diagnostics assay results and was considered a false-negative FFPE FISH result. FISH failure occurred mainly in the older archived slides because of overdigestion (n = 5), hybridization failure (n = 5), or excessive background fluorescence (n = 3). CONCLUSIONS: Non-CB cytology smears are highly suitable for multiplex FISH analysis with 100% concordance with FFPE FISH and/or ALK D5F3 companion diagnostics assay results. CI - Copyright (c) 2022 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved. FAU - Nambirajan, Aruna AU - Nambirajan A AD - Departments of Pathology, All India Institute of Medical Sciences, New Delhi, India. FAU - Rana, Deeksha AU - Rana D AD - Departments of Pathology, All India Institute of Medical Sciences, New Delhi, India. FAU - Samant, Komal AU - Samant K AD - Departments of Pathology, All India Institute of Medical Sciences, New Delhi, India. FAU - Prabakaran, Aswini AU - Prabakaran A AD - Departments of Pathology, All India Institute of Medical Sciences, New Delhi, India. FAU - Malik, Prabhat AU - Malik P AD - Department of Medical Oncology, Dr. B.R.A.IRCH, All India Institute of Medical Sciences, New Delhi, India. FAU - Jain, Deepali AU - Jain D AD - Departments of Pathology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: deepalijain76@gmail.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220113 PL - United States TA - J Am Soc Cytopathol JT - Journal of the American Society of Cytopathology JID - 101613234 RN - 0 (Proto-Oncogene Proteins) RN - 1HG84L3525 (Formaldehyde) RN - EC 2.7.10.1 (Anaplastic Lymphoma Kinase) RN - EC 2.7.10.1 (Protein-Tyrosine Kinases) SB - IM MH - *Adenocarcinoma of Lung MH - Anaplastic Lymphoma Kinase/genetics MH - Formaldehyde MH - Gene Rearrangement MH - Humans MH - In Situ Hybridization, Fluorescence/methods MH - *Lung Neoplasms/pathology MH - Oncogenes MH - Paraffin Embedding MH - Protein-Tyrosine Kinases/genetics MH - Proto-Oncogene Proteins/genetics OTO - NOTNLM OT - ALK OT - Cytology smear OT - Lung adenocarcinoma OT - Multiplex FISH OT - ROS1 EDAT- 2022/02/13 06:00 MHDA- 2022/04/21 06:00 CRDT- 2022/02/12 05:28 PHST- 2021/12/11 00:00 [received] PHST- 2021/12/28 00:00 [revised] PHST- 2022/01/05 00:00 [accepted] PHST- 2022/02/13 06:00 [pubmed] PHST- 2022/04/21 06:00 [medline] PHST- 2022/02/12 05:28 [entrez] AID - S2213-2945(22)00001-1 [pii] AID - 10.1016/j.jasc.2022.01.001 [doi] PST - ppublish SO - J Am Soc Cytopathol. 2022 May-Jun;11(3):154-164. doi: 10.1016/j.jasc.2022.01.001. Epub 2022 Jan 13.